Close Menu

NEW YORK (GenomeWeb) – Rosetta Genomics today announced that it has signed a deal to promote Precipio Diagnostics' oncology tests in certain US states, with plans to expand nationally later on.

Through a network of collaborations with Yale School and Medicine and other academic institutes, New Haven, Conn.-based Precipio offers a suite of molecular diagnostics that it tailors to patients' disease based on pathology and symptoms.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers representing scientists and students of Chinese descent voice their concerns about recent US policies and rhetoric.

Wired reports that researchers have shown they could reprogram a DNA-based computer.

Researchers say increased diversity in genomic studies will benefit all, PBS NewsHour reports.

In Science this week: whole-genome sequencing of single sperm cells, and more.

Apr
17
Sponsored by
Isoplexis

This webinar will provide an overview of current biomarker strategies for guiding the use of combination checkpoint immunotherapies in blood cancers.

Apr
30
Sponsored by
Lexogen

This webinar will discuss novel long-read transcript sequencing (LRTseq) methods for transcriptome annotation that could increase the efficiency and accuracy of future sequencing projects.